ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ICU vs SINT // EV/EBITDA & P/E VALUATION

SeaStar Medical Holding Corporation (NASDAQ) VS. SiNtx Technologies Inc. (NASDAQ) • 15-METRIC TALLY: ICU 2 — SINT 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ICU VS. SINT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ICU SINT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 95.70% 45.30% +50.40 ICU /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 180.00% -64.70% +244.70 ICU /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 4/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 35.4 43.1 -7.72 SINT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $12.2M $13.0M -$847.3K SINT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ICU REV SINT REV ICU GROSS % SINT GROSS % ICU FCF SINT FCF
FY 2025 $1.2M $1.0M 95.7% 45.3% -$13.6M -$8.8M
FY 2024 $135.0K $2.9M 98.0% 71.9% -$16.0M -$9.3M
FY 2023 $0 $2.6M — — -$10.3M -$14.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ICU // BETA —
SINT // BETA —